Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Abbott Laboratories (ABT), The Chubb Corporation (CB), And Three Stocks That Offer Protection From Market Tantrums

Page 1 of 2

The economy is only just starting to chug along again.  The situation in Europe is relatively unchanged, China is slowing down and banks are still de-leveraging. Yet stock markets are hitting all-time highs. With these mixed market messages, many investors and market commentators are confused about whether the market is overstretched or just warming up.

Wherever we go from here, it is always handy to have stocks in your portfolio that offer some protection from the trend in the general market.

How to defend your portfolio

This is where beta comes in. Beta is an indicator of the systemic risk of a stock in comparison to the market as a whole. For example, a beta of 1 would indicate that the company’s share price moves in line with the market: when the market moves down 1%, the stock price tends to move down 1% with it.

A beta of more than 1, for example 1.5, would indicate that the stock moves more than the market, in this case 50% more (when the market moves 1% the stock tends to move 1.5%). Any stock with a beta of less than 1 is in theory less volatile than the market.

Now, I must mention here that the beta figure is an average of past data. That means that the stock’s future movement in relation to the market is only theoretical. Even with this caveat, beta is a good indicator of how volatile stocks can be.

As an example, here is a chart comparing the price action of General Mills, Inc. (NYSE:GIS), Cliffs Natural Resources Inc (NYSE:CLF), and the S&P 500.

General Mills’ beta figure is around 0.17, depending somewhat on who calculates the figure. Cliffs has a beta of around 2.4, indicating that the stock has moved, on average, 2.4% for every 1% that the market moved.

Cliffs Natural Resources Inc (NYSE:CLF)’s share price has been all over the place during the last few years as volatile commodity prices, rising costs and falling profits have dented investors’ confidence; this is the reason behind the company’s high beta.

In comparison, General Mills, Inc. (NYSE:GIS)’s operations have been relatively stable, and profits and earnings have grown steadily, drawing investors to the stock. This steady uptrend and lack of volatility is the reason for the company’s low beta.

The Vanguard Consumer Staples ETF has a low beta of 0.6 due to its defensive nature:

During 2008, 2009 and 2011 the ETF did not fall nearly as much as the wider market due to its defensive nature, resulting in the ETF’s low beta.

These examples highlight the benefits of selecting stocks with a low beta.

So where to invest?

A low beta figure indicates that a stock could be a safe haven in a falling market. However, in my opinion buying a stock just because it has a low beta can be unwise, as beta is only one indicator.

Buying stocks that are undervalued and have a low beta figure, in my opinion, is the best way of defending a portfolio against market volatility. Here are three low beta stocks undervalued against their peers that could offer a safe haven in this uncertain market.

Contender number one

Abbott Laboratories (NYSE:ABT)Abbott Laboratories (NYSE:ABT) has a forward P/E of 16, lower than its peers in the rest of the sector, which have an average P/E of 42. Moreover, the company has a P/B ratio of 2.1 against the sector average of 3.3. Abbott Laboratories (NYSE:ABT)appears to be undervalued against the rest of the sector thanks to its defensive nature, and the company has a low beta of around 0.3.

Abbott Laboratories (NYSE:ABT) has shown a very low correlation to market movements during the past five years, indicating that it is a good choice for a defensive portfolio.

Page 1 of 2
Loading Comments...